Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is treated through injections of anti-VEGF drugs like Lucentis or Avastin into the affected eye to prevent vision loss. Poland's public healthcare offers free treatment for citizens.
Poland has a well-developed healthcare system, with diagnostic waiting times varying from 1 to 3 weeks.